Dr. Smith Advises Clinicians on Diagnosing Double-Hit and Triplet-Hit Lymphoma

Sonali M. Smith, MD
Published: Wednesday, Sep 05, 2018



Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, advises clinicians on diagnosing double-hit and triple-hit lymphoma in patients with diffuse large B-cell lymphoma (DLBCL).

Double-hit and triplet-hit lymphomas are uncommon but not rare, and needs to be looked for in patients diagnosed with DLBCL, Smith says. This subtype is enriched in patients with a germinal center phenotype, as well in those with high-risk features. Smith says that the most important thing is to take a big enough biopsy. If there is a suspicion for an aggressive B-cell lymphoma, Smith advises clinicians to take enough tissue to test for it during initial biopsy.

The most important thing to do when a patient presents with a double-hit lymphoma is to confirm the diagnosis with the pathologist, Smith says. Nuances including amplification, copy number alterations, and mutations can make a difference. Additionally, Smith says that R-CHOP is not going to be sufficient, and clinicians should consider a more intensive therapeutic regimen for these patients.
SELECTED
LANGUAGE


Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, advises clinicians on diagnosing double-hit and triple-hit lymphoma in patients with diffuse large B-cell lymphoma (DLBCL).

Double-hit and triplet-hit lymphomas are uncommon but not rare, and needs to be looked for in patients diagnosed with DLBCL, Smith says. This subtype is enriched in patients with a germinal center phenotype, as well in those with high-risk features. Smith says that the most important thing is to take a big enough biopsy. If there is a suspicion for an aggressive B-cell lymphoma, Smith advises clinicians to take enough tissue to test for it during initial biopsy.

The most important thing to do when a patient presents with a double-hit lymphoma is to confirm the diagnosis with the pathologist, Smith says. Nuances including amplification, copy number alterations, and mutations can make a difference. Additionally, Smith says that R-CHOP is not going to be sufficient, and clinicians should consider a more intensive therapeutic regimen for these patients.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x